Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial
Joanna M. Zakrzewska(Institute of Cardiology), Simon Tate(Ricardo Prague (Czechia)), Dominique Derjean, Lars Bendtsen(University of Copenhagen), Kevin P. Gunn, Dominik A. Ettlin, Mark Obermann(University of Duisburg-Essen), Gary Layton(University of Geneva), G. Cruccu(Apple (Israel)), Valérie Morisset, Joanne Palmer, Mark Estación(Yale University), Gerard M.P. Giblin, Stephen G. Waxman(Yale University)
Cited by 201